Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Transient Depletion of Innate Immunity Provides a Two-step Approach to Improve the Delivery of Tumour Targeted Nanoparticles

FY 2015-16

Summary
The ability to design nanoparticles that are a billionth of the size of a human hair to carry drugs and minimize their toxic side-effects remains highly advantageous toward the development of new chemotherapeutics. The chemistry of the nanoparticles can be designed to improve biocompatibility and to offer controlled and systemic release of a drug at a tumor. The challenge with most nanoparticles is that they are sequestered by the resident immune system of the liver and spleen. These organs contain white blood cells or macrophages that remove nanoparticles from the blood stream and limit their accumulation in a solid tumor. We have developed a strategy to improve the delivery of chemotherapeutics to a solid tumor by temporarily removing a portion of these macrophages at a dose that does not compromise the patient immune system. For some of the engineered nanoparticles, a forty-fold increased accumulation in the tumour was seen using this approach. This two-step delivery strategy will greatly improve the efficacy of nano-chemotherapeutics for the treatment of cancer without compromising patient susceptibility to infection.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
339419
Name
Tavares Anthony J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Transient Depletion of Innate Immunity Provides a Two-step Approach to Improve the Delivery of Tumour Targeted Nanoparticles
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Chemotherapy; Delivery; Nanoparticles; Tumour; Xenograft
Abstract
The ability to design nanoparticles that are a billionth of the size of a human hair to carry drugs and minimize their toxic side-effects remains highly advantageous toward the development of new chemotherapeutics. The chemistry of the nanoparticles can be designed to improve biocompatibility and to offer controlled and systemic release of a drug at a tumor. The challenge with most nanoparticles is that they are sequestered by the resident immune system of the liver and spleen. These organs contain white blood cells or macrophages that remove nanoparticles from the blood stream and limit their accumulation in a solid tumor. We have developed a strategy to improve the delivery of chemotherapeutics to a solid tumor by temporarily removing a portion of these macrophages at a dose that does not compromise the patient immune system. For some of the engineered nanoparticles, a forty-fold increased accumulation in the tumour was seen using this approach. This two-step delivery strategy will greatly improve the efficacy of nano-chemotherapeutics for the treatment of cancer without compromising patient susceptibility to infection.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Tavares, Anthony J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~
University of Toronto - $135,000 Grant (2015-16) | Canada Spends